235 related articles for article (PubMed ID: 34656208)
1. Effects of implementing universal and rapid HIV treatment on initiation of antiretroviral therapy and retention in care in Zambia: a natural experiment using regression discontinuity.
Mody A; Sikazwe I; Namwase AS; Wa Mwanza M; Savory T; Mwila A; Mulenga L; Herce ME; Mweebo K; Somwe P; Eshun-Wilson I; Sikombe K; Beres LK; Pry J; Holmes CB; Bolton-Moore C; Geng EH
Lancet HIV; 2021 Dec; 8(12):e755-e765. PubMed ID: 34656208
[TBL] [Abstract][Full Text] [Related]
2. Estimating the real-world effects of expanding antiretroviral treatment eligibility: Evidence from a regression discontinuity analysis in Zambia.
Mody A; Sikazwe I; Czaicki NL; Wa Mwanza M; Savory T; Sikombe K; Beres LK; Somwe P; Roy M; Pry JM; Padian N; Bolton-Moore C; Holmes CB; Geng EH
PLoS Med; 2018 Jun; 15(6):e1002574. PubMed ID: 29870531
[TBL] [Abstract][Full Text] [Related]
3. Temporal changes in paediatric and adolescent HIV outcomes across the care continuum in Zambia: an interrupted time-series analysis.
Bolton-Moore C; Sikazwe I; Mubiana-Mbewe M; Munthali G; Wa Mwanza M; Savory T; Nkhoma L; Somwe P; Namwase AS; Geng EH; Mody A
Lancet HIV; 2022 Aug; 9(8):e563-e573. PubMed ID: 35905754
[TBL] [Abstract][Full Text] [Related]
4. Universal test-and-treat in Zambian and South African correctional facilities: a multisite prospective cohort study.
Herce ME; Hoffmann CJ; Fielding K; Topp SM; Hausler H; Chimoyi L; Smith HJ; Chetty-Makkan CM; Mukora R; Tlali M; Olivier AJ; Muyoyeta M; Reid SE; Charalambous S
Lancet HIV; 2020 Dec; 7(12):e807-e816. PubMed ID: 32763152
[TBL] [Abstract][Full Text] [Related]
5. Twelve months antiretroviral therapy retention among clients newly enrolled to care and treatment services in Geita Regin, Tanzania: does universal test and treat matter?
Masuke R; Kihaga Y; Mashala M; Ndalio S; Sukari O; Panga O
Pan Afr Med J; 2023; 46():20. PubMed ID: 38035160
[TBL] [Abstract][Full Text] [Related]
6. Impact of the test and treat policy on delays in antiretroviral therapy initiation among adult HIV positive patients from six clinics in Johannesburg, South Africa: results from a prospective cohort study.
Onoya D; Sineke T; Hendrickson C; Mokhele I; Maskew M; Long LC; Fox M
BMJ Open; 2020 Mar; 10(3):e030228. PubMed ID: 32213514
[TBL] [Abstract][Full Text] [Related]
7. Attrition in HIV care following HIV diagnosis: a comparison of the pre-UTT and UTT eras in South Africa.
Onoya D; Hendrickson C; Sineke T; Maskew M; Long L; Bor J; Fox MP
J Int AIDS Soc; 2021 Feb; 24(2):e25652. PubMed ID: 33605061
[TBL] [Abstract][Full Text] [Related]
8. Effect of the "universal test and treat" policy on the characteristics of persons registering for HIV care and initiating antiretroviral therapy in Uganda.
Mugenyi L; Hansen CH; Mayaud P; Seeley J; Newton R; Nanfuka M; Abaasa A; Mugisha K; Etukoit M; Kaleebu P; Ruzagira E
Front Public Health; 2023; 11():1187274. PubMed ID: 37361157
[TBL] [Abstract][Full Text] [Related]
9. Costs of implementing universal test and treat in three correctional facilities in South Africa and Zambia.
Mukora R; Smith HJ; Herce ME; Chimoyi L; Hausler H; Fielding KL; Charalambous S; Hoffmann CJ
PLoS One; 2022; 17(8):e0272595. PubMed ID: 36006967
[TBL] [Abstract][Full Text] [Related]
10. Effect of universal test and treat on retention and mortality among people living with HIV-infection in Uganda: An interrupted time series analysis.
Mugenyi L; Nanfuka M; Byawaka J; Agaba C; Mijumbi A; Kagimu D; Mugisha K; Shabbar J; Etukoit M
PLoS One; 2022; 17(5):e0268226. PubMed ID: 35580126
[TBL] [Abstract][Full Text] [Related]
11. Retention on antiretroviral therapy during Universal Test and Treat implementation in Zomba district, Malawi: a retrospective cohort study.
Alhaj M; Amberbir A; Singogo E; Banda V; van Lettow M; Matengeni A; Kawalazira G; Theu J; Jagriti MR; Chan AK; van Oosterhout JJ
J Int AIDS Soc; 2019 Feb; 22(2):e25239. PubMed ID: 30734510
[TBL] [Abstract][Full Text] [Related]
12. CD4+ T-Cell Count at Antiretroviral Therapy Initiation in the "Treat-All" Era in Rural South Africa: An Interrupted Time Series Analysis.
Yapa HM; Kim HY; Petoumenos K; Post FA; Jiamsakul A; De Neve JW; Tanser F; Iwuji C; Baisley K; Shahmanesh M; Pillay D; Siedner MJ; Bärnighausen T; Bor J
Clin Infect Dis; 2022 Apr; 74(8):1350-1359. PubMed ID: 34309633
[TBL] [Abstract][Full Text] [Related]
13. Retention and viral suppression in a cohort of HIV patients on antiretroviral therapy in Zambia: Regionally representative estimates using a multistage-sampling-based approach.
Sikazwe I; Eshun-Wilson I; Sikombe K; Czaicki N; Somwe P; Mody A; Simbeza S; Glidden DV; Chizema E; Mulenga LB; Padian N; Duncombe CJ; Bolton-Moore C; Beres LK; Holmes CB; Geng E
PLoS Med; 2019 May; 16(5):e1002811. PubMed ID: 31150380
[TBL] [Abstract][Full Text] [Related]
14. Towards 90-90: Findings after two years of the HPTN 071 (PopART) cluster-randomized trial of a universal testing-and-treatment intervention in Zambia.
Floyd S; Ayles H; Schaap A; Shanaube K; MacLeod D; Phiri M; Griffith S; Bock P; Beyers N; Fidler S; Hayes R;
PLoS One; 2018; 13(8):e0197904. PubMed ID: 30096139
[TBL] [Abstract][Full Text] [Related]
15. Patient-reported reasons for declining same-day antiretroviral therapy initiation in routine HIV care settings in Lusaka, Zambia: results from a mixed-effects regression analysis.
Pry J; Chipungu J; Smith HJ; Bolton Moore C; Mutale J; Duran-Frigola M; Savory T; Herce ME
J Int AIDS Soc; 2020 Jul; 23(7):e25560. PubMed ID: 32618137
[TBL] [Abstract][Full Text] [Related]
16. Treatment eligibility and retention in clinical HIV care: A regression discontinuity study in South Africa.
Bor J; Fox MP; Rosen S; Venkataramani A; Tanser F; Pillay D; Bärnighausen T
PLoS Med; 2017 Nov; 14(11):e1002463. PubMed ID: 29182641
[TBL] [Abstract][Full Text] [Related]
17. Timing and Predictors of Initiation on Antiretroviral Therapy Among Newly-Diagnosed HIV-Infected Persons in South Africa.
Larsen A; Cheyip M; Tesfay A; Vranken P; Fomundam H; Wutoh A; Aynalem G
AIDS Behav; 2019 Feb; 23(2):375-385. PubMed ID: 30008050
[TBL] [Abstract][Full Text] [Related]
18. Factors associated with antiretroviral treatment initiation amongst HIV-positive individuals linked to care within a universal test and treat programme: early findings of the ANRS 12249 TasP trial in rural South Africa.
Boyer S; Iwuji C; Gosset A; Protopopescu C; Okesola N; Plazy M; Spire B; Orne-Gliemann J; McGrath N; Pillay D; Dabis F; Larmarange J;
AIDS Care; 2016; 28 Suppl 3(Suppl 3):39-51. PubMed ID: 27421051
[TBL] [Abstract][Full Text] [Related]
19. Predictors of timely linkage-to-ART within universal test and treat in the HPTN 071 (PopART) trial in Zambia and South Africa: findings from a nested case-control study.
Sabapathy K; Mubekapi-Musadaidzwa C; Mulubwa C; Schaap A; Hoddinott G; Stangl A; Floyd S; Ayles H; Fidler S; Hayes R;
J Int AIDS Soc; 2017 Dec; 20(4):. PubMed ID: 29251433
[TBL] [Abstract][Full Text] [Related]
20. What do the Universal Test and Treat trials tell us about the path to HIV epidemic control?
Havlir D; Lockman S; Ayles H; Larmarange J; Chamie G; Gaolathe T; Iwuji C; Fidler S; Kamya M; Floyd S; Moore J; Hayes R; Petersen M; Dabis F;
J Int AIDS Soc; 2020 Feb; 23(2):e25455. PubMed ID: 32091179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
